Quality of life in primary and recurrent glioblastoma patients: The impact of resection and adjuvant treatment, a single centre prospective study

M. Rapp, Y. Kriese, M. Göppert, W. Stummer, H.-J. Steiger & M. Sabel
Objective: Treatment for glioblastoma (GBM) patients has become more effective due to alkylating chemotherapy (both local and systemic) and maximal resection, resulting in an increase in overall survival. Evaluations of these concepts have mainly focused on survival parameters and toxicity. We performed[for full text, please go to the a.m. URL]